COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Clin Infect Dis. 2021 Oct 5;73(7):1805-1813. doi: 10.1093/cid/ciaa1166.
The evidence base for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is nascent. We sought to characterize SARS-CoV-2 transmission within US households and estimate the household secondary infection rate (SIR) to inform strategies to reduce transmission.
We recruited patients with laboratory-confirmed SARS-CoV-2 infection and their household contacts in Utah and Wisconsin during 22 March 2020-25 April 2020. We interviewed patients and all household contacts to obtain demographics and medical histories. At the initial household visit, 14 days later, and when a household contact became newly symptomatic, we collected respiratory swabs from patients and household contacts for testing by SARS-CoV-2 real-time reverse-transcription polymerase chain reaction (rRT-PCR) and sera for SARS-CoV-2 antibodies testing by enzyme-linked immunosorbent assay (ELISA). We estimated SIR and odds ratios (ORs) to assess risk factors for secondary infection, defined by a positive rRT-PCR or ELISA test.
Thirty-two (55%) of 58 households secondary infection among household contacts. The SIR was 29% (n = 55/188; 95% confidence interval [CI], 23%-36%) overall, 42% among children (aged <18 years) of the COVID-19 patient and 33% among spouses/partners. Household contacts to COVID-19 patients with immunocompromised conditions and household contacts who themselves had diabetes mellitus had increased odds of infection with ORs 15.9 (95% CI, 2.4-106.9) and 7.1 (95% CI: 1.2-42.5), respectively.
We found substantial evidence of secondary infections among household contacts. People with COVID-19, particularly those with immunocompromising conditions or those with household contacts with diabetes, should take care to promptly self-isolate to prevent household transmission.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的证据基础尚处于初期阶段。我们试图描述美国家庭内 SARS-CoV-2 的传播情况,并估计家庭二次感染率(SIR),为减少传播的策略提供信息。
我们于 2020 年 3 月 22 日至 4 月 25 日期间在犹他州和威斯康星州招募了实验室确诊 SARS-CoV-2 感染的患者及其家庭接触者。我们对患者和所有家庭接触者进行访谈,以获取人口统计学和病史信息。在首次家庭访问时、14 天后以及家庭接触者出现新症状时,我们从患者和家庭接触者采集呼吸道拭子进行 SARS-CoV-2 实时逆转录聚合酶链反应(rRT-PCR)检测,并采集血清进行 SARS-CoV-2 抗体酶联免疫吸附试验(ELISA)检测。我们通过 rRT-PCR 或 ELISA 检测评估了二次感染的 SIR 和比值比(OR),以评估二次感染的风险因素。
在 58 个家庭中,有 32 个(55%)家庭接触者发生了二次感染。总体 SIR 为 29%(n=55/188;95%置信区间[CI],23%-36%),COVID-19 患者的儿童(年龄<18 岁)为 42%,配偶/伴侣为 33%。COVID-19 患者有免疫功能低下情况的家庭接触者和自身患有糖尿病的家庭接触者发生感染的可能性更大,OR 分别为 15.9(95%CI,2.4-106.9)和 7.1(95%CI:1.2-42.5)。
我们发现家庭接触者中存在大量的二次感染证据。COVID-19 患者,尤其是有免疫功能低下情况的患者或有糖尿病家庭接触者的患者,应注意及时自我隔离,以防止家庭内传播。